Engineered oncolytic virus armed with anti-PCSK9 scFv boosts long-term CD8(+) T cell immunity via rewiring MHC-I antigen presentation. (linkinghub.elsevier.com)

Authors: Feng H … Xing F Journal: Cell Reports Medicine Published: 2026-04-21 DOI: https://doi.org/10.1016/j.xcrm.2026.102724